The Ethos Podcast - Congresses and the ABPI Code
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
The Ethos Podcast - Congresses and the ABPI Code
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode, Dr Nick Broughton sits down with Dr Ravi Pawa to unpack one of the most complex areas of pharmaceutical compliance: how the ABPI Code of Practice applies to congress activity.
Together, they explore the questions keeping compliance teams and medical leaders up at night:
-
Does Clause 8.2 mean UK clinicians at international congresses fall under the UK Code?
-
How should companies handle UK delegates who attend global events?
-
What does recent ABPI guidance mean for who can (and cannot) access congress exhibition areas?
-
How can pharma balance regulatory expectations with the realities of global science and collaboration?
Drawing on their deep experience as signatories and senior decision-makers in pharma, Nick and Ravi share practical perspectives on maintaining ethical standards without isolating UK science or overburdening compliance teams.
If you work in compliance, medical affairs, or commercial pharma, this conversation will give you fresh insight into how to navigate congresses with confidence under the ABPI Code.